One year in review 2018

systemic vasculitis

Elena Elefante, Milena Bond, Sara Monti, Gemma Lepri, Elena Cavallaro, Mara Felicetti, Emanuele Calabresi, Chiara Posarelli, Rosaria Talarico, Luca Quartuccio, Chiara Baldini

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Systemic vasculitis are heterogeneous, complex and disabling disorders. Following the previous annual reviews of this series, this paper gives a brief overview on current knowledge about recent literature on small- and large-vessel systemic vasculitis, with a specific focus on pathogenetic and clinical aspects, novel possible disease-related biomarkers and current and future therapies that are in the pipeline.

Original languageEnglish
Pages (from-to)12-32
Number of pages21
JournalClinical and Experimental Rheumatology
Volume36
Issue number2
Publication statusPublished - Mar 1 2018
Externally publishedYes

Fingerprint

Systemic Vasculitis
Biomarkers
Therapeutics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Elefante, E., Bond, M., Monti, S., Lepri, G., Cavallaro, E., Felicetti, M., ... Baldini, C. (2018). One year in review 2018: systemic vasculitis. Clinical and Experimental Rheumatology, 36(2), 12-32.

One year in review 2018 : systemic vasculitis. / Elefante, Elena; Bond, Milena; Monti, Sara; Lepri, Gemma; Cavallaro, Elena; Felicetti, Mara; Calabresi, Emanuele; Posarelli, Chiara; Talarico, Rosaria; Quartuccio, Luca; Baldini, Chiara.

In: Clinical and Experimental Rheumatology, Vol. 36, No. 2, 01.03.2018, p. 12-32.

Research output: Contribution to journalReview article

Elefante, E, Bond, M, Monti, S, Lepri, G, Cavallaro, E, Felicetti, M, Calabresi, E, Posarelli, C, Talarico, R, Quartuccio, L & Baldini, C 2018, 'One year in review 2018: systemic vasculitis', Clinical and Experimental Rheumatology, vol. 36, no. 2, pp. 12-32.
Elefante E, Bond M, Monti S, Lepri G, Cavallaro E, Felicetti M et al. One year in review 2018: systemic vasculitis. Clinical and Experimental Rheumatology. 2018 Mar 1;36(2):12-32.
Elefante, Elena ; Bond, Milena ; Monti, Sara ; Lepri, Gemma ; Cavallaro, Elena ; Felicetti, Mara ; Calabresi, Emanuele ; Posarelli, Chiara ; Talarico, Rosaria ; Quartuccio, Luca ; Baldini, Chiara. / One year in review 2018 : systemic vasculitis. In: Clinical and Experimental Rheumatology. 2018 ; Vol. 36, No. 2. pp. 12-32.
@article{7d7b97c3d87b479b97ac9c331b104566,
title = "One year in review 2018: systemic vasculitis",
abstract = "Systemic vasculitis are heterogeneous, complex and disabling disorders. Following the previous annual reviews of this series, this paper gives a brief overview on current knowledge about recent literature on small- and large-vessel systemic vasculitis, with a specific focus on pathogenetic and clinical aspects, novel possible disease-related biomarkers and current and future therapies that are in the pipeline.",
author = "Elena Elefante and Milena Bond and Sara Monti and Gemma Lepri and Elena Cavallaro and Mara Felicetti and Emanuele Calabresi and Chiara Posarelli and Rosaria Talarico and Luca Quartuccio and Chiara Baldini",
year = "2018",
month = "3",
day = "1",
language = "English",
volume = "36",
pages = "12--32",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "2",

}

TY - JOUR

T1 - One year in review 2018

T2 - systemic vasculitis

AU - Elefante, Elena

AU - Bond, Milena

AU - Monti, Sara

AU - Lepri, Gemma

AU - Cavallaro, Elena

AU - Felicetti, Mara

AU - Calabresi, Emanuele

AU - Posarelli, Chiara

AU - Talarico, Rosaria

AU - Quartuccio, Luca

AU - Baldini, Chiara

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Systemic vasculitis are heterogeneous, complex and disabling disorders. Following the previous annual reviews of this series, this paper gives a brief overview on current knowledge about recent literature on small- and large-vessel systemic vasculitis, with a specific focus on pathogenetic and clinical aspects, novel possible disease-related biomarkers and current and future therapies that are in the pipeline.

AB - Systemic vasculitis are heterogeneous, complex and disabling disorders. Following the previous annual reviews of this series, this paper gives a brief overview on current knowledge about recent literature on small- and large-vessel systemic vasculitis, with a specific focus on pathogenetic and clinical aspects, novel possible disease-related biomarkers and current and future therapies that are in the pipeline.

UR - http://www.scopus.com/inward/record.url?scp=85050726234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050726234&partnerID=8YFLogxK

M3 - Review article

VL - 36

SP - 12

EP - 32

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 2

ER -